Abacavir does not influence the rate of sustained virological response in HIV-HCV co-infected patients treated with pegylated interferon and weight adjusted ribavirin

Por N, Laufer, M, Laguno, I, Perez, C, Cifuentes, J, Murillas, F, Vidal, L, Bonet, S, Veloso, JM, Gatell, J, Mallolas
Publicado em 2008